Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Epidemics
Recent news which mentions Epidemics
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
25
26
Next >
Op-Ed: NYC Health Commissioner Dr. Chokshi says Covid pandemic has left U.S. with new epidemic of loneliness
March 09, 2022
Tags
Health & Science
Business
Pandemics
From
CNBC.com News
U.S. far from normal with Covid deaths 10 times higher than seasonal respiratory viruses, report says
March 07, 2022
Tags
US Top News and Analysis
US Economy
Health care industry
From
CNBC.com News
Secretary of State Blinken tells NATO ally Lithuania 'an attack on one is an attack on all'
March 07, 2022
Tags
US Economy
Health care industry
US Top News and Analysis
From
CNBC.com News
Moderna reaches preliminary agreement to build Covid vaccine manufacturing plant in Africa
March 07, 2022
Tags
Policy
Breaking News: Business
Coronavirus
From
CNBC.com News
New Jersey will end omicron public health emergency, NYC to lift indoor vaccine mandate
March 04, 2022
Tags
Biotech and Pharmaceuticals
Asia News
US Economy
From
CNBC.com News
Watch live: Ukraine President Zelenskyy addresses European capital cities as Russia presses invasion
March 04, 2022
Tags
Europe News
Markets
International Homepage
From
CNBC.com News
More than 90% of U.S. population can ditch facemasks under CDC Covid guidance
March 03, 2022
Tags
US Economy
Health care industry
US Top News and Analysis
From
CNBC.com News
What's next for Pfizer, Moderna beyond their projected $51 billion in combined Covid vaccine sales this year
March 03, 2022
Tags
Moderna Inc
Biotech and Pharmaceuticals
US Top News and Analysis
From
CNBC.com News
WHO says war in Ukraine will increase Covid transmission, putting large numbers of people at risk of severe disease
March 02, 2022
Tags
Business News
Disease outbreaks
U/S/ Economy
From
CNBC.com News
People who test positive for Covid can receive antiviral pills at pharmacies for free, Biden says
March 01, 2022
Tags
Politics
Biotechnology
Policy
From
CNBC.com News
Biden says U.S. will deploy new Covid vaccines within 100 days if another variant emerges
March 01, 2022
Tags
Biotech and Pharmaceuticals
Health care industry
US Economy
From
CNBC.com News
Ukraine asked the internet's governing body to remove Russian sites
March 01, 2022
Tags
Biotechnology
Politics
Technology
From
CNBC.com News
Pfizer Covid vaccine was just 12% effective against omicron in kids 5 to 11, study finds
February 28, 2022
Tags
Business
Pandemics
World News
From
CNBC.com News
Ukraine hospitals could run out of oxygen supplies in 24 hours as war disrupts health services, WHO says
February 27, 2022
Tags
U/S/ Economy
Disease outbreaks
Business News
From
CNBC.com News
CDC relaxes mask guidance allowing most people to ditch masks if hospitalizations remain low
February 25, 2022
Tags
Business News
Disease outbreaks
U/S/ Economy
From
CNBC.com News
Omicron BA.2 subvariant is more contagious and can reinfect people, but isn't more severe, studies find
February 25, 2022
Tags
Business News
Disease outbreaks
U/S/ Economy
From
CNBC.com News
Moderna says Covid is entering an endemic phase, but annual vaccines will be needed
February 24, 2022
Tags
Biotechnology
Politics
Coronavirus
From
CNBC.com News
Moderna expects at least $19 billion in Covid vaccine sales in 2022, reports big fourth-quarter earnings beat
February 24, 2022
Tags
Policy
Breaking News: Business
Coronavirus
From
CNBC.com News
CDC says waiting longer between Pfizer, Moderna doses may reduce rare myocarditis risk for younger men
February 23, 2022
Tags
Business News
U/S/ Economy
Disease outbreaks
From
CNBC.com News
Covid infections plummet 90% from U.S. pandemic high, states lift mask mandates
February 22, 2022
Tags
Business News
Disease outbreaks
U/S/ Economy
From
CNBC.com News
California prepares to live with Covid, laying out plan to fight future surges and new variants
February 17, 2022
Tags
Health & Science
US: News
World News
From
CNBC.com News
CDC wants to give people a break from wearing masks as pandemic improves, director says
February 16, 2022
Tags
Health & Science
Pandemics
Business
From
CNBC.com News
Babies are protected from hospitalization for Covid if their moms get vaccinated, study suggests
February 15, 2022
Tags
Biotech and Pharmaceuticals
US Top News and Analysis
Health care industry
From
CNBC.com News
Senate confirms Biden FDA pick Califf, despite objections to drug industry ties
February 15, 2022
Tags
Pandemics
US: News
Health & Science
From
CNBC.com News
Moderna, Pfizer stocks fall as omicron Covid wave subsides in U.S.
February 14, 2022
Tags
BioNTech SE
Coronavirus
Epidemics
From
CNBC.com News
FDA plan to fast-track Pfizer vaccine for kids under 5 fails to deliver, leaving parents waiting until April
February 12, 2022
Tags
Politics
Biotechnology
Breaking News: Business
From
CNBC.com News
No one knows when the pandemic will end after omicron upended most hope of returning to normal
February 11, 2022
Tags
Merck & Co Inc
Disease outbreaks
US Top News and Analysis
From
CNBC.com News
FDA committee votes against Eli Lilly cancer treatment over concerns trials conducted only in China
February 10, 2022
Tags
Policy
Breaking News: Business
Coronavirus
From
CNBC.com News
The CDC still needs to approve young kids' Covid shots, but it's telling health agencies to expect delivery by Feb. 21
February 09, 2022
Tags
Business News
Disease outbreaks
U/S/ Economy
From
CNBC.com News
Watch live: New York Gov. Hochul is expected to lift indoor mask mandate
February 09, 2022
Tags
Asia Markets
World News
Business
From
CNBC.com News
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.